MedPath

Laparoscopic Transvaginal Hybrid Anterior Resection: a Prospective Data Collection

Completed
Conditions
Sigmoid Diverticulitis (Hinchey I and II)
Sigmoid Diverticulosis With Two or More Attacks of Diverticulitis
Interventions
Procedure: Laparoscopic transvaginal hybrid anterior resection
Registration Number
NCT01043731
Lead Sponsor
Cantonal Hospital of St. Gallen
Brief Summary

Transvaginal hybrid procedures are of interest as an available NOTES-Procedure for the clinical routine. Few authors have demonstrated the feasibility and safety of such procedures (e.g. cholecystectomy) in selected patient collectives. In 2008 Lacy at al. published the experience with a transvaginal sigmoidectomy as a first in human report. The aim of this prospective data collection is to evaluate the feasibility and safety of the transvaginal hybrid anterior resection in the clinical routine.

Therefore all patients giving the informed consent to the transvaginal hybrid anterior resection will be included and assessed concerning feasibility to perform the transvaginal approach and complete the operation transvaginally.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
Female
Target Recruitment
45
Inclusion Criteria
  • given informed consent
  • sigmoid diverticulosis (two or more attacks)
  • sigmoid diverticulitis (Hinchey I and II)
Exclusion Criteria
  • ASA IV
  • emergency surgery
  • liver-malfunction or coagulation disorders
  • acute diverticulitis (Hinchey III and IV)
  • malignancy
  • acute vaginal infection
  • refusal of mandatory preoperative gynecological examination
  • pregnancy
  • endometriosis
  • previous surgery of colon and rectum
  • strongly retroflexed uterus
  • acute pelvic disorders, infection

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
Ginven indication for laparoscopic anterior resectionLaparoscopic transvaginal hybrid anterior resection-
Primary Outcome Measures
NameTimeMethod
Feasibility and safety of the transvaginal operation30 days
Secondary Outcome Measures
NameTimeMethod
Long-term life quality and sexual dysfunction3 year

Trial Locations

Locations (1)

Department of surgery

🇨🇭

St. Gallen, Switzerland

© Copyright 2025. All Rights Reserved by MedPath